Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages

Journal of Clinical Investigation

Volumn 115, Issue 9, 2005, Pages 2363-2372

  Maruyama, Kazuichi ^a   Ii, Masaaki ^b   Cursiefen, Claus ^a,f   Jackson, David G ^c   Keino, Hiroshi ^a   Tomita, Minoru ^a   Van Rooijen, Nico ^d   Takenaka, Hideya ^b   D'Amore, Patricia A ^a   Stein Streilein, Joan ^a,e   Losordo, Douglas W ^b   Streilein, J Wayne ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; CD11B ANTIGEN; CELL MARKER; GLYCOPROTEIN P 15095; PODOPLANIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENDOTHELIUM CELL; IN VITRO STUDY; INNATE IMMUNITY; KERATITIS; LYMPH FLOW; LYMPHANGIOGENESIS; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD11B; CORNEA; CORNEAL TRANSPLANTATION; ENDOTHELIAL CELLS; GLYCOPROTEINS; INFLAMMATION; LYMPHANGIOGENESIS; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS;

EID: 24644474779     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI23874     Document Type: Article

References (41)

1. Cursiefen, C., Chen, L., Dana, M.R., and Streilein, J.W. 2003. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology [review]. Cornea. 22:273-281.
2. Streilein, J.W., Yamada, J., Dana, M.R., and Ksander, B.R. 1999. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. Transplant. Proc. 31:1472-1475.
3. Dana, M.R., and Streilein, J.W. 1996. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 37:2485-2494.
4. Cursiefen, C., et al. 2004. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113:1040-1050. doi: 10.1172/JCI200420465.
5. Jackson, D.G. 2001. New molecular markers for the study of tumour lymphangiogenesis. Anticancer Res. 21:4279-4283.
6. Casley-Smith, J.R. 1980. The fine structure and functioning of tissue channels and lymphatics. Lymphology. 13:177-183.
7. Leak, L.V. 1970. Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface. Microvasc. Res. 2:361-391.
8. Cursiefen, C., et al. 2002. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest. Ophthalmol. Vis. Sci. 43:2127-2135.
9. Skobe, M., et al. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7:192-198.
10. Breiteneder-Geleff, S., et al. 1997. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am. J. Pathol. 151:1141-1152.
11. Breiteneder-Geleff, S., et al. 1999. Podoplanin-a specific marker for lymphatic endothelium expressed in angiosarcoma [In German]. Verb. Dtsch. Ges. Pathol. 83:270-275.
12. Sinzelle, E., et al. 2000. Intrapericardial lymphangioma with podoplanin immunohistochemical characterization of lymphatic endothelial cells. Histopathology. 37:93-94.
13. Weninger, W., et al. 1999. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab. Invest. 79:243-251.
14. Banerji, S., et al. 1999. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144:789-801.
15. Prevo, R., Banerji, S., Ferguson, D.J., Clasper, S., and Jackson, D.G. 2001. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J. Biol. Chem. 276:19420-19430.
16. Wigle, J.T., et al. 2002. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenorype. EMBO J. 21:1505-1513.
17. Wigle, J.T., Chowdhury, K., Gruss, P., and Oliver, G. 1999. Prox1 function is crucial for mouse lens-fibre elongation. Nat. Genet. 21:318-322.
18. Hamrah, P., Liu, Y., Zhang, Q., and Dana, M.R. 2003. The corneal stroma is endowed with a significant number of resident dendritic cells. Invest. Ophthalmol. Vis. Sci. 44:581-589.
19. Mimura, T., et al. 2001. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis. Exp. Eye Res. 72:71-78.
20. Hamrah, P., et al. 2004. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva. Exp. Eye Res. 79:553-561.
21. Skobe, M., et al. 2001. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am. J. Pathol. 159:893-903.
22. Schoppmann, S.F., et al. 2002. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 161:947-956.
23. Loughman, M.S., et al. 1996. Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factor. Aust. N. Z. J. Ophthalmol. 24:289-295.
24. Gimbrone, M.A., Jr., Leapman, S.B., Cotran, R.S., and Folkman, J. 1973. Tumor angiogenesis: iris neovascularization at a distance from experimental intraocular tumors. J. Natl. Cancer Inst. 50:219-228.
25. Hamrah, P., Huq, S.O., Liu, Y., Zhang, Q., and Dana, M.R. 2003. Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J. Leukoc. Biol. 74:172-178.
26. Schilling, M., et al. 2003. Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp. Neurol. 183:25-33.
27. Takahashi, T., et al. 1999. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5:434-438.
28. Rehman, J., Li, J., Orschell, C.M., and March, K.L. 2003. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation. 107:1164-1169.
29. Hong, Y.K., et al. 2002. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn. 225:351-357.
30. van Rooijen, N., Bakker, J., and Sanders, A. 1997. Transient suppression of macrophage functions by liposome-encapsulated drugs. Trends Biotechnol. 15:178-185.
31. Biewenga, J., et al. 1995. Macrophage depletion in the rat after intraperitoneal administration of liposome-encapsulaced clodronate: depletion kinetics and accelerated repopulation of peritoneal and omental macrophages by administration of Freund's adjuvant. Cell Tissue Res. 280:189-196.
32. van Rooijen, N., Kors, N., van der Ende, M., and Dijkstra, C.D. 1990. Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res. 260:215-222.
33. Oh, S.J., et al. 1997. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol. 188:96-109.
34. Karkkainen, M.J., et al. 2003. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5:74-80.
35. Cao, R., et al. 2004. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell. 6:333-345.
36. Sonoda, Y., and Streilein, J.W. 1992. Orthotopic corneal transplantation in mice-evidence that the immunogenetic rules of rejection do not apply. Transplantation. 54:694-704.
37. Chang, L., Kaipainen, A., and Folkman, J. 2002. Lymphangiogenesis new mechanisms. Ann. N. Y. Acad. Sci. 979:111-119.
38. Schlaeger, T.M., Qin, Y., Fujiwara, Y., Magram, J., and Sato, T.N. 1995. Vascular endothelial cell lineage-specific promoter in transgenic mice. Development. 121:1089-1098.
39. Puri, M.C., Rossant, J., Alitalo, K., Bernstein, A., and Partanen, J. 1995. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J. 14:5884-5891.
40. Ambati, J., et al. 2003. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat. Med. 9:1390-1397.
41. Takeuchi, M., Alard, P., and Streilein, J.W. 1998. TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells. J. Immunol. 160:1589-1597.